ATXI — Avenue Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $1.48m
- -$1.37m
- $1.40m
Annual cashflow statement for Avenue Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.73 | -3.6 | -10.5 | -11.7 | -2.95 |
| Non-Cash Items | 0.442 | -4.4 | 1.33 | 2.49 | 0.814 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.461 | 0.408 | -0.29 | 0.179 | 0.3 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -3.75 | -7.6 | -9.45 | -9.03 | -1.83 |
| Other Investing Cash Flow Items | 0 | — | -3 | 0 | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | — | -3 | 0 | — |
| Financing Cash Flow Items | -0.663 | -0.508 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 4.38 | 10.5 | 7.53 | 9.84 | 2.09 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.631 | 2.94 | -4.92 | 0.811 | 0.261 |